Pegylated liposomal doxorubicin re-challenge in patients with ovarian cancer relapse: a multicenter retrospective study | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

Original Article

Pegylated liposomal doxorubicin re-challenge in patients with ovarian cancer relapse: a multicenter retrospective study

Online download statistics by month:

Online download statistics by month: January 2019 to July 2020

	Abstract	Full	Pdf
Jan 2019	0	21	8
Feb 2019	0	9	8
Mar 2019	299	6	9
Apr 2019	172	2	2
May 2019	120	7	0
Jun 2019	70	1	0
Jul 2019	100	3	1
Aug 2019	70	1	1
Sep 2019	68	4	2
Oct 2019	71	2	2
Nov 2019	82	0	1
Dec 2019	103	3	2
Jan 2020	93	0	0
Feb 2020	62	0	0
Mar 2020	58	0	0
Apr 2020	39	0	1
May 2020	41	0	0
Jun 2020	48	1	1
Jul 2020	12	0	0
Total	1508	60	38